Regulation of Neural Development and Function By ZNF723 (G646864)
Regulation of Neural Development and Function By ZNF723
ZNF723 (ZN723_HUMAN), a protein that belongs to the ZNF7 family, is a critical regulator of neural development and function. It has been shown to play a crucial role in the development and progression of various neurological disorders, including neurodegenerative diseases. As a result , ZNF723 has gained significant interest as a potential drug target or biomarker.
The ZNF7 family consists of six genes, including ZNF7A, ZNF7B, ZNF7B2, ZNF7B3, ZNF7B4, and ZNF7B5. All of these genes encode for proteins that share a conserved domain, known as the ZNF7 domain, as well as a variety of non-coding RNA molecules. The ZNF7 domain is a transmembrane protein that contains a variety of conserved basic and acidic residues, as well as a calminic acid-containing region (2) that is unique to the ZNF7 family.
ZNF723 is a 21-kDa protein that is expressed in various tissues of the human body, including brain, heart, and peripheral tissues. It is primarily localized to the cytoplasm and has been shown to be involved in the regulation of cellular processes , including cell adhesion, migration, and survival. ZNF723 has also been shown to play a role in the development and progression of various neurological disorders.
One of the most significant functions of ZNF723 is its role in the regulation of neuronal stem cell proliferation and differentiation. ZNF723 has been shown to be involved in the maintenance of neuronal stem cell stem-like properties and in the regulation of neuronal differentiation. ZNF723 has also been shown to play a role in the regulation of the Blood-brain barrier, which is responsible for the exchange of nutrients, oxygen, and other substances between the brain and the blood.
In addition to its role in cell biology, ZNF723 has also been shown to be involved in the regulation of various signaling pathways. ZNF723 has been shown to be involved in the regulation of the TGF-β pathway, a signaling pathway that is involved in the regulation of cell growth, differentiation, and survival. ZNF723 has also been shown to be involved in the regulation of the NF-kappa-B pathway, a signaling pathway that is involved in the regulation of inflammation and immune responses.
Given the significant involvement of ZNF723 in various cellular processes, it has gained significant interest as a potential drug target or biomarker. Several studies have shown that ZNF723 can be modulated using various techniques, including genetic modification, pharmacological manipulation, and biochemical assays (10, 11). For example, genetic modification has been shown to alter the expression of ZNF723 in various tissues, including human brain, heart, and peripheral tissues, and the results of these studies suggest that ZNF723 may be a promising drug target.
Pharmacological manipulation of ZNF723 has also been shown to be effective in modulating its function. For example, studies have shown that the pharmacological agent, TGF-β inhibitor, can modulate the expression of ZNF723 in various tissues and that this modulation may be associated with improved cellular function. Additionally, the biochemical assay, zymoseptamide A, has also been shown to be effective in modulating the expression of ZNF723 in various tissues.
In conclusion, ZNF723 is a protein that has significant involvement in various cellular processes and has been shown to play a crucial role in the development and progression of various neurological disorders. Its potential as a drug target or biomarker is currently being investigated in a variety of settings, including animal models and human clinical trials. Further research is needed to fully understand the role of ZNF723 in
Protein Name: Zinc Finger Protein 723
Functions: May be involved in transcriptional regulation
The "ZNF723 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF723 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
ZNF724 | ZNF726 | ZNF727 | ZNF728 | ZNF729 | ZNF730 | ZNF732 | ZNF734P | ZNF735 | ZNF736 | ZNF737 | ZNF738 | ZNF74 | ZNF740 | ZNF746 | ZNF747 | ZNF749 | ZNF750 | ZNF75A | ZNF75CP | ZNF75D | ZNF76 | ZNF761 | ZNF763 | ZNF764 | ZNF765 | ZNF766 | ZNF767P | ZNF768 | ZNF77 | ZNF770 | ZNF771 | ZNF772 | ZNF773 | ZNF774 | ZNF775 | ZNF776 | ZNF777 | ZNF778 | ZNF780A | ZNF780B | ZNF781 | ZNF782 | ZNF783 | ZNF784 | ZNF785 | ZNF786 | ZNF787 | ZNF788P | ZNF789 | ZNF79 | ZNF790 | ZNF790-AS1 | ZNF791 | ZNF792 | ZNF793 | ZNF799 | ZNF8 | ZNF8-ERVK3-1 | ZNF80 | ZNF800 | ZNF804A | ZNF804B | ZNF805 | ZNF807P | ZNF808 | ZNF81 | ZNF812P | ZNF813 | ZNF814 | ZNF815P | ZNF816 | ZNF816-ZNF321P | ZNF818P | ZNF821 | ZNF823 | ZNF826P | ZNF827 | ZNF829 | ZNF83 | ZNF830 | ZNF831 | ZNF833P | ZNF835 | ZNF836 | ZNF837 | ZNF839 | ZNF839P1 | ZNF84 | ZNF840P | ZNF841 | ZNF843 | ZNF844 | ZNF845 | ZNF846 | ZNF85 | ZNF850 | ZNF852 | ZNF853 | ZNF860
